Assignee
ICOS CORP
US·159 granted patents·28 pending applications·4,856 citations·filing 1975–2020
Top patents by PatentIndex Score
187 records- 0198US8980901B25-fluoro-3-phenyl-2[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2013·Granted Mar 17, 2015·39 cites·21 claims
- 0298USRE44599EQuinazolinones as inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2012·Granted Nov 12, 2013·44 cites·6 claims
- 0398US7932260B2Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2005·Granted Apr 26, 2011·221 cites·2 claims
- 0498US6949535B2Inhibitors of human phosphatidyl-inositol 3-kinase deltaICOS CORP·Filed 2003·Granted Sep 27, 2005·172 cites·15 claims
- 0598US6667300B2Inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2001·Granted Dec 23, 2003·174 cites·12 claims
- 0698US6518277B1Inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2001·Granted Feb 11, 2003·272 cites·13 claims
- 0798US5859006ATetracyclic derivatives; process of preparation and useICOS CORP·Filed 1995·Granted Jan 12, 1999·208 cites·15 claims
- 0897US8779131B26-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)-ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2013·Granted Jul 15, 2014·30 cites·10 claims
- 0997US8586597B26-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2012·Granted Nov 19, 2013·36 cites·6 claims
- 1097US6521619B2Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agentsICOS CORP·Filed 2001·Granted Feb 18, 2003·103 cites·9 claims
- 1196US8993583B25-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2013·Granted Mar 31, 2015·22 cites·13 claims
- 1296US5888809AHamster EF-1α transcriptional regulatory DNAICOS CORP·Filed 1997·Granted Mar 30, 1999·221 cites·29 claims
- 1395US10010550B2Inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2017·Granted Jul 3, 2018·11 cites·2 claims
- 1495US9487772B2Inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2013·Granted Nov 8, 2016·19 cites·1 claims
- 1595US9149477B25-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)propyl]-3h-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2014·Granted Oct 6, 2015·17 cites·12 claims
- 1695US5985589ALipid kinaseICOS CORP·Filed 1999·Granted Nov 16, 1999·171 cites·5 claims
- 1795US5858753ALipid kinaseICOS CORP·Filed 1996·Granted Jan 12, 1999·191 cites·10 claims
- 1894US6423710B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2000·Granted Jul 23, 2002·47 cites·27 claims
- 1994US6043252ACarboline derivativesICOS CORP·Filed 1998·Granted Mar 28, 2000·90 cites·14 claims
- 2093US6348602B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2000·Granted Feb 19, 2002·49 cites·33 claims
- 2193US6306870B1N-cinnamoyl derivatives of beta-carbolineICOS CORP·Filed 2000·Granted Oct 23, 2001·63 cites·22 claims
- 2292US10398695B2Inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2018·Granted Sep 3, 2019·5 cites·2 claims
- 2392US6268477B1Chemokine receptor 88-CICOS CORP·Filed 1996·Granted Jul 31, 2001·77 cites·1 claims
- 2492US6265184B1Polynucleotides encoding chemokine receptor 88CICOS CORP·Filed 1995·Granted Jul 24, 2001·75 cites·11 claims
- 2591US10695349B2Inhibitors of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2019·Granted Jun 30, 2020·2 cites·2 claims
- 2691US10336756B2(S)-2-(1-aminopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one precursor of a quinazolinone as inhibitor of human phosphatidylinositol 3-kinase deltaICOS CORP·Filed 2015·Granted Jul 2, 2019·5 cites·2 claims
- 2791US6486186B2Thiazole compounds as cyclic AMP-specific phosphodiesterase inhibitors and method of using the sameICOS CORP·Filed 2001·Granted Nov 26, 2002·43 cites·5 claims
- 2891US6203790B1Platelet-activating factor acetylhydrolaseICOS CORP·Filed 2000·Granted Mar 20, 2001·21 cites·2 claims
- 2991US6143746ATetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and useICOS CORP·Filed 1998·Granted Nov 7, 2000·112 cites·13 claims
- 3091US5880268AModulators of the interaction between ICAM-R and αd /CD18ICOS CORP·Filed 1995·Granted Mar 9, 1999·78 cites·1 claims
- 3190US6372777B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2000·Granted Apr 16, 2002·36 cites·26 claims
- 3290US5882910ALipid kinaseICOS CORP·Filed 1997·Granted Mar 16, 1999·64 cites·1 claims
- 3389US7067506B2Compounds useful for inhibiting Chk1ICOS CORP·Filed 2002·Granted Jun 27, 2006·31 cites·25 claims
- 3489US6797811B1Antibodies to chemokine receptor 88CICOS CORP·Filed 1996·Granted Sep 28, 2004·56 cites·14 claims
- 3589US6458787B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2001·Granted Oct 1, 2002·24 cites·22 claims
- 3689US6432404B1Methods of inhibiting locomotor damage following spinal cord injury with α D-specific antibodiesICOS CORP·Filed 2000·Granted Aug 13, 2002·38 cites·9 claims
- 3788US7608618B2Urea or thiourea substituted 1,4-pyrazine compounds useful as anti-cancer agents and for inhibiting Chk1ICOS CORP·Filed 2005·Granted Oct 27, 2009·9 cites·2 claims
- 3888US6258833B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 1999·Granted Jul 10, 2001·55 cites·37 claims
- 3988US6140329AUse of cGMP-phosphodiesterase inhibitors in methods and compositions to treat impotenceICOS CORP·Filed 1996·Granted Oct 31, 2000·72 cites·21 claims
- 4088US5932703AMacrophage derived chemokine and chemokine analogsICOS CORP·Filed 1996·Granted Aug 3, 1999·72 cites·5 claims
- 4187US6680336B2Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2002·Granted Jan 20, 2004·23 cites·4 claims
- 4287US6444671B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2001·Granted Sep 3, 2002·16 cites·34 claims
- 4386US6294561B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2000·Granted Sep 25, 2001·22 cites·37 claims
- 4486US5981527ACyclic GMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 1996·Granted Nov 9, 1999·68 cites·13 claims
- 4585US6734003B2Phosphodiesterase 10ICOS CORP·Filed 2001·Granted May 11, 2004·10 cites·2 claims
- 4685US6569890B2Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2002·Granted May 27, 2003·19 cites·28 claims
- 4785US6500856B2Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2001·Granted Dec 31, 2002·20 cites·4 claims
- 4885US6369059B1Tetracyclic derivatives, process of preparation and useICOS CORP·Filed 2000·Granted Apr 9, 2002·15 cites·3 claims
- 4985US6313156B1Thiazole compounds as cyclic-AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2000·Granted Nov 6, 2001·20 cites·35 claims
- 5084US7560462B2Compounds useful for inhibiting CHK1ICOS CORP·Filed 2005·Granted Jul 14, 2009·7 cites·3 claims
Showing the top 50 of 187 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →